ReviewStem cell research & therapy2026
Quercetin-loaded composite materials for bone regeneration: a review of carriers, controlled release, and mechanistic advances.
Review in Stem cell research & therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Quercetin is a natural flavonoid with strong antioxidant, anti-inflammatory, and osteogenic effects, showing great promise for bone regeneration. However, its poor solubility, low bioavailability, and rapid degradation limit clinical use. Innovative quercetin-loaded composite biomaterials address these challenges by providing precise, controlled release and enhancing therapeutic efficacy. In recent years, quercetin-loaded composite materials have shown significant research progress in the field of bone tissue engineering. Studies indicate that in vitro experiments demonstrate the excellent biocompatibility of these materials, which promote osteogenic differentiation, induce macrophage polarization toward the M2 phenotype, scavenge reactive oxygen species, exert antibacterial effects, and enhance angiogenesis. In vivo studies confirm that quercetin-loaded composite materials increase bone volume, density, and vascularization, with various signaling pathways. This review integrates novel mechanistic insights, addresses challenges like optimal dosing and smart responsiveness, and outlines pathways for quercetin composites in repairing complex bone defects, paving the way for advanced regenerative therapies with strong clinical potential.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.